story of the week
A 12-Gene Pharmacogenetic Panel to Prevent Adverse Drug Reactions
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
Lancet 2023 Feb 04;401(10374)347-356, JJ Swen, CH van der Wouden, LE Manson, H Abdullah-Koolmees, K Blagec, T Blagus, S Böhringer, A Cambon-Thomsen, E Cecchin, KC Cheung, VH Deneer, M Dupui, M Ingelman-Sundberg, S Jonsson, C Joefield-Roka, KS Just, MO Karlsson, L Konta, R Koopmann, M Kriek, T Lehr, C Mitropoulou, E Rial-Sebbag, V Rollinson, R Roncato, M Samwald, E Schaeffeler, M Skokou, M Schwab, D Steinberger, JC Stingl, R Tremmel, RM Turner, MH van Rhenen, CL Dávila Fajardo, V Dolžan, GP Patrinos, M Pirmohamed, G Sunder-Plassmann, G Toffoli, HJ GuchelaarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.